{"id":124670,"date":"2025-07-22T10:22:09","date_gmt":"2025-07-22T10:22:09","guid":{"rendered":"https:\/\/www.aboca.com\/informativa-e-privatesise-sistemi-i-farmakovigjilences\/"},"modified":"2026-03-04T08:44:27","modified_gmt":"2026-03-04T08:44:27","slug":"informativa-e-privatesise-sistemi-i-farmakovigjilences","status":"publish","type":"page","link":"https:\/\/www.aboca.com\/sq\/informativa-e-privatesise-sistemi-i-farmakovigjilences\/","title":{"rendered":"Informativa e privat\u00ebsis\u00eb &#8211; Sistemi i Farmakovigjilenc\u00ebs"},"content":{"rendered":"<div class=\"not-on-desktop\" style=\"padding-top:0; padding-bottom:0;\"><ul class=\"commonBreads__list \">\n            <li class=\"commonBreads__item text__body-breads\">\n            \n            <a   title=\"Home\"   role=\"none\" >Home<\/a>\n            \n                    <\/li>\n\n    <\/ul>\n<\/div>\n\n<p><strong>Privacy Notice \u2013 Pharmacovigilance System<\/strong><\/p>\n\n<p><strong>Neni 13 Regj. BE 679 m\u00eb 27 Prill 2016 <\/strong><\/p>\n\n<p>N\u00eb p\u00ebrputhje me Nenin 13 t\u00eb Rregullores Evropiane 2016\/679 (GDPR), p\u00ebr mbrojtjen e personave fizik\u00eb n\u00eb lidhje me trajtimin e t\u00eb dh\u00ebnave personale dhe qarkullimin e lir\u00eb t\u00eb k\u00ebtyre t\u00eb dh\u00ebnave, ABOCA S.p.A. Shoq\u00ebri Bujq\u00ebsore (n\u00eb vijim \u201cABOCA\u201d), me seli n\u00eb Loc. Aboca 20, Sansepolcro (AR) \u2013 52037, Arezzo, Itali, me detyr\u00eb si Titullare e trajtimit, \u00ebsht\u00eb e detyruar t&#8217;u ofroj\u00eb p\u00ebrdoruesve t\u00eb faqes s\u00eb internetit <a href=\"https:\/\/www.aboca.com\/sq\/\">www.aboca.com<\/a> disa informacione q\u00eb kan\u00eb lidhje me trajtimin e t\u00eb dh\u00ebnave t\u00eb tyre personale.  <\/p>\n\n<p>Titullari i trajtimit:<br\/>ABOCA S.p.A. Shoq\u00ebri Bujq\u00ebsore, me seli n\u00eb Loc. Aboca 20, 52037 Sansepolcro (AR).  <\/p>\n\n<p>P\u00ebrgjegj\u00ebsi p\u00ebr mbrojtjen e t\u00eb dh\u00ebnave (RPD):<br\/>Av. Giuseppe Serafini, Dhoma e avokat\u00ebve Perugia.<br\/>E-mail: <a href=\"mailto:dpo@aboca.it\">dpo@aboca.it<\/a> <\/p>\n\n<p class=\"has-custom-size\" style=\"font-size:24px\"><strong><strong><u>P\u00ebrkufizime kryesore p\u00ebr t&#8217;ju ndihmuar q\u00eb t\u00eb lexoni k\u00ebt\u00eb Informativ\u00eb<\/u><\/strong><\/strong><\/p>\n\n<p>Vigjilenca: \u00ebsht\u00eb grupi i aktiviteteve q\u00eb synojn\u00eb identifikimin, vler\u00ebsimin, kuptimin dhe parandalimin e efekteve t\u00eb d\u00ebmshme ose t\u00eb \u00e7do problemi tjet\u00ebr q\u00eb lidhet me p\u00ebrdorimin e pajisjeve mjek\u00ebsore, integrator\u00ebve ushqimor\u00eb dhe kozmetik\u00ebve. Objektivi i saj kryesor \u00ebsht\u00eb t\u00eb siguroj\u00eb q\u00eb produktet t\u00eb p\u00ebrdoren n\u00eb m\u00ebnyr\u00eb t\u00eb sigurt, duke siguruar nj\u00eb raport t\u00eb favorsh\u00ebm p\u00ebrfitimi\/rreziku p\u00ebr popullsin\u00eb.  <\/p>\n\n<p>Pajisje mjek\u00ebsore: \u00e7do instrument, aparat, aparatur\u00eb, softuer, impiant, reagent, material ose ndonj\u00eb artikull tjet\u00ebr, i destinuar nga fabrikuesi p\u00ebr t&#8217;u p\u00ebrdorur te njer\u00ebzit, vet\u00ebm ose i kombinuar, p\u00ebr nj\u00eb ose m\u00eb shum\u00eb q\u00ebllime p\u00ebrdorimi mjek\u00ebsore specifike si n\u00eb vijim:<\/p>\n\n<ul class=\"has-custom-size has-custom-lineheight wp-block-list\" style=\"line-height:2;font-size:20px\">\n<li>diagnoz\u00eb, parandalim, monitorim, parashikim, prognoz\u00eb, trajtim ose zbutje t\u00eb s\u00ebmundjeve,<\/li>\n<\/ul>\n\n<ul class=\"has-custom-size has-custom-lineheight wp-block-list\" style=\"line-height:2;font-size:20px\">\n<li>diagnostikim, monitorim, trajtim, zbutje ose kompensim i nj\u00eb l\u00ebndimi ose i nj\u00eb paaft\u00ebsie,<\/li>\n<\/ul>\n\n<ul class=\"has-custom-size has-custom-lineheight wp-block-list\" style=\"line-height:1.5;font-size:20px\">\n<li>studim, z\u00ebvend\u00ebsim ose modifikim i anatomis\u00eb ose i nj\u00eb procesi ose gjendjeje fiziologjike ose patologjike,<\/li>\n<\/ul>\n\n<ul class=\"has-custom-size has-custom-lineheight wp-block-list\" style=\"line-height:2;font-size:20px\">\n<li>sigurimi i informacioneve n\u00ebp\u00ebrmjet analizave in vitro t\u00eb mostrave me prejardhje nga trupi i njeriut, duke p\u00ebrfshir\u00eb gjakun dhe indet e dhuruara,<\/li>\n<\/ul>\n\n<ul class=\"wp-block-list\">\n<li>dhe q\u00eb nuk ushtron n\u00eb ose mbi trupin e njeriut veprimin kryesor p\u00ebr t\u00eb cilin \u00ebsht\u00eb i destinuar me an\u00ebn e mjeteve farmakologjike, imunologjike ose metabolike, por funksioni i t\u00eb cilit mund t\u00eb ndihmohet nga t\u00eb tilla mjete.<\/li>\n<\/ul>\n\n<p>Integrator ushqimor: produkte ushqimore t\u00eb destinuara p\u00ebr t\u00eb integruar diet\u00ebn normale dhe q\u00eb p\u00ebrb\u00ebjn\u00eb nj\u00eb burim t\u00eb koncentruar l\u00ebnd\u00ebsh ushqyese ose substancash t\u00eb tjera me nj\u00eb efekt ushqyes ose fiziologjik, qoft\u00eb me nj\u00eb p\u00ebrb\u00ebr\u00ebs (monokomposte) ose me shum\u00eb p\u00ebrb\u00ebr\u00ebs (plurikomposte), n\u00eb forma dozimi, d.m.th., n\u00eb forma t\u00eb tregtuara si kapsula, hape, tableta, pilula dhe produkte t\u00eb ngjashme, pluhura n\u00eb bustina, l\u00ebngje n\u00eb ampula, flakone me pikatore dhe forma t\u00eb tjera t\u00eb ngjashme t\u00eb l\u00ebngjeve dhe pluhurave t\u00eb destinuara p\u00ebr t&#8217;u marr\u00eb n\u00eb sasi t\u00eb vogla monodoz\u00eb.<\/p>\n\n<p>Kozmetik\u00eb: \u00e7do substanc\u00eb ose p\u00ebrzierje e destinuar p\u00ebr t&#8217;u aplikuar mbi sip\u00ebrfaqet e jashtme t\u00eb trupit t\u00eb njeriut (epiderm\u00eb, sistem qimesh dhe flok\u00ebsh, thonj, buz\u00eb, organe gjenitale t\u00eb jashtme) ose mbi dh\u00ebmb\u00eb dhe mbi mukozat e goj\u00ebs duke pasur si q\u00ebllim t\u00eb vet\u00ebm ose kryesor pastrimin e tyre, parfumosjen e tyre, ndryshimin e pamjes, mbrojtjes, mbajtjes s\u00eb tyre n\u00eb gjendje t\u00eb mir\u00eb ose p\u00ebr t\u00eb korrigjuar aromat e trupit.<\/p>\n\n<p>Operator i Sektorit Ushqimor: Personi fizik ose juridik p\u00ebrgjegj\u00ebs p\u00ebr t\u00eb garantuar respektimin e dispozitave t\u00eb legjislacionit alimentar n\u00eb nd\u00ebrmarrjen ushqimore t\u00eb v\u00ebn\u00eb n\u00ebn kontrollin e tij.<\/p>\n\n<p>Person p\u00ebrgjegj\u00ebs: nj\u00eb person fizik ose juridik q\u00eb \u00ebsht\u00eb i caktuar si \u00abperson p\u00ebrgjegj\u00ebs\u00bb brenda Komunitetit dhe q\u00eb garanton respektimin e detyrimeve p\u00ebrkat\u00ebse t\u00eb vendosura nga rregullorja mbi produktet kozmetike.<\/p>\n\n<p>Fabrikanti nj\u00eb person fizik ose juridik q\u00eb fabrikon nj\u00eb produkt kozmetik ose e projekton nj\u00eb t\u00eb till\u00eb ose e fabrikon dhe e tregton at\u00eb duke v\u00ebn\u00eb emrin ose mark\u00ebn e tij tregtare.<\/p>\n\n<p>Efekt i pad\u00ebshiruesh\u00ebm: nj\u00eb reagim negativ ndaj sh\u00ebndetit t\u00eb njeriut q\u00eb rezulton nga p\u00ebrdorimi normal ose i parashikuesh\u00ebm n\u00eb m\u00ebnyr\u00eb t\u00eb arsyeshme i nj\u00eb produkti t\u00eb grupit Aboca.<\/p>\n\n<p>T\u00eb dh\u00ebna personale: Informacion q\u00eb identifikon nj\u00eb person fizik.<\/p>\n\n<p>Sinjalizues: Nj\u00eb person q\u00eb komunikon t\u00eb dh\u00ebnat e tij sh\u00ebndet\u00ebsore ose ato t\u00eb pal\u00ebve t\u00eb treta.<\/p>\n\n<p class=\"has-custom-size\" style=\"font-size:24px\"><strong><u>Fusha e aplikimit<\/u><\/strong><\/p>\n\n<p>Garantimi i siguris\u00eb s\u00eb pacientit \u00ebsht\u00eb nj\u00eb p\u00ebrpar\u00ebsi absolute p\u00ebr Aboca. P\u00ebr k\u00ebt\u00eb arsye, ne e marrim shum\u00eb seriozisht p\u00ebrdorimin e sigurt t\u00eb t\u00eb gjitha produkteve tona (pajisje mjek\u00ebsore, integrator\u00eb dhe kozmetik\u00eb).  <\/p>\n\n<p>\u00cbsht\u00eb thelb\u00ebsore t\u00eb jemi n\u00eb gjendje t\u00eb lidhemi me njer\u00ebzit q\u00eb na sinjalizojn\u00eb (sinjalizues) informacione mbi sigurin\u00eb n\u00eb lidhje me produktet tona, n\u00eb m\u00ebnyr\u00eb q\u00eb t\u00eb mbledhim detaje t\u00eb m\u00ebtejshme, t&#8217;u p\u00ebrgjigjemi k\u00ebrkesave dhe t\u00eb ofrojm\u00eb materialin e nevojsh\u00ebm.<\/p>\n\n<p>Kjo informativ\u00eb ilustron se si i mbledhim dhe i p\u00ebrdorim t\u00eb dh\u00ebnat personale q\u00eb marrim p\u00ebr t\u00eb p\u00ebrmbushur detyrimet tona t\u00eb Vigjilenc\u00ebs dhe p\u00ebr t\u00eb garantuar sigurin\u00eb e t\u00eb gjitha produkteve tona.<\/p>\n\n<p>Kjo informativ\u00eb ka t\u00eb b\u00ebj\u00eb me mbledhjen dhe p\u00ebrdorimin e t\u00eb dh\u00ebnave personale p\u00ebr t\u00eb garantuar sigurin\u00eb e produkteve Aboca.<\/p>\n\n<p>Regjistrimi dhe analiza e sinjalizimeve dhe mbledhja sistematike dhe e kujdesshme e t\u00eb dh\u00ebnave nuk \u00ebsht\u00eb vet\u00ebm nj\u00eb k\u00ebrkes\u00eb teknike, por nj\u00eb shtyll\u00eb themelore p\u00ebr t\u00eb garantuar q\u00eb Vigjilenca (mbik\u00ebqyrja) t\u00eb mund t\u00eb kryej\u00eb rolin e saj n\u00eb m\u00ebnyr\u00eb proaktive, duke mbrojtur sh\u00ebndetin publik dhe duke promovuar p\u00ebrdorimin e sigurt dhe t\u00eb p\u00ebrgjegjsh\u00ebm t\u00eb produkteve.<\/p>\n\n<p>T\u00eb dh\u00ebnat p\u00ebrdoren:<\/p>\n\n<ul class=\"has-custom-size has-custom-lineheight wp-block-list\" style=\"line-height:1.5;font-size:20px\">\n<li>P\u00ebr t\u00eb marr\u00eb informacionin e nevojsh\u00ebm p\u00ebr sinjalizimet.<\/li>\n<\/ul>\n\n<ul class=\"has-custom-size has-custom-lineheight wp-block-list\" style=\"line-height:1.5;font-size:20px\">\n<li>P\u00ebr t&#8217;iu p\u00ebrgjigjur k\u00ebrkesave t\u00eb p\u00ebrdoruesve.<\/li>\n<\/ul>\n\n<ul class=\"has-custom-size has-custom-lineheight wp-block-list\" style=\"line-height:1.5;font-size:20px\">\n<li>P\u00ebr t\u00eb monitoruar sigurin\u00eb dhe cil\u00ebsin\u00eb e produktit.<\/li>\n<\/ul>\n\n<p>Natyra e t\u00eb dh\u00ebnave dhe e dor\u00ebzimit t\u00eb tyre<\/p>\n\n<p>Mund t\u00eb mbledhim informacionet e m\u00ebposhtme n\u00eb lidhje me personin e interesuar:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>inicialet;<\/li>\n\n\n\n<li>gjinia;<\/li>\n\n\n\n<li>dat\u00eblindja;<\/li>\n\n\n\n<li>mosha;<\/li>\n\n\n\n<li>origjina etnike;<\/li>\n\n\n\n<li>dozimi;<\/li>\n\n\n\n<li>emri i produktit;<\/li>\n\n\n\n<li>parti malli;<\/li>\n\n\n\n<li>motivi i p\u00ebrdorimit;<\/li>\n\n\n\n<li>data e fillimit dhe e fundit e reaksionit;<\/li>\n\n\n\n<li>p\u00ebrshkrim i detajuar i efektit an\u00ebsor;<\/li>\n\n\n\n<li>po vazhdon ta marr\u00eb produktin;<\/li>\n\n\n\n<li>informacione t\u00eb detajuara mbi produktet e tjera (ila\u00e7e, pajisje mjek\u00ebsore, integrator\u00eb ushqimor\u00eb, kozmetik\u00eb) q\u00eb po merrni ose po merrnit n\u00eb koh\u00ebn e efektit t\u00eb pad\u00ebshiruar ose t\u00eb k\u00ebrkes\u00ebs p\u00ebr informacione, duke p\u00ebrfshir\u00eb doz\u00ebn q\u00eb keni marr\u00eb ose q\u00eb ju \u00ebsht\u00eb p\u00ebrshkruar;<\/li>\n\n\n\n<li>rezultati i reagimit deri m\u00eb sot (n\u00eb vazhdim, i zgjidhur, i p\u00ebrmir\u00ebsuar, etj.);<\/li>\n\n\n\n<li>anamneza personale dhe familjare (alergji, patologji t\u00eb tjera, etj.);<\/li>\n\n\n\n<li>analiza eventuale (n\u00ebse jan\u00eb b\u00ebr\u00eb).<\/li>\n<\/ul>\n\n<p>N\u00eb lidhje me sinjalizuesin, nj\u00eb person i ndrysh\u00ebm nga pacienti\/subjekti i k\u00ebrkes\u00ebs, mund t\u00eb mbledhim t\u00eb dh\u00ebnat e m\u00ebposhtme:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>emrin dhe t\u00eb dh\u00ebnat e kontaktit (q\u00eb mund t\u00eb p\u00ebrfshijn\u00eb adres\u00ebn, adres\u00ebn e-mail, numrin e telefonit ose numrin e faksit);<\/li>\n\n\n\n<li>marr\u00ebdh\u00ebnien me personin p\u00ebr t\u00eb cilin \u00ebsht\u00eb d\u00ebrguar sinjalizimi.<\/li>\n<\/ul>\n\n<p>Dor\u00ebzimi nuk \u00ebsht\u00eb i detyruesh\u00ebm, por \u00ebsht\u00eb i domosdosh\u00ebm p\u00ebr t\u00eb ndjekur sinjalizimin e ngjarjes s\u00eb pad\u00ebshiruar q\u00eb lidhet me p\u00ebrdorimin e nj\u00eb produkti Aboca.<\/p>\n\n<p>Mungesa e dor\u00ebzimit nuk do t\u00eb b\u00ebj\u00eb t\u00eb mundur administrimin e sinjalizimit.<\/p>\n\n<p><strong>Q\u00ebllimet dhe baza ligjore e trajtimit<\/strong><\/p>\n\n<p>T\u00eb dh\u00ebnat personale t\u00eb mbledhura mund t\u00eb p\u00ebrdoren p\u00ebr q\u00ebllimet e m\u00ebposhtme:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>Shqyrtimi i ngjarjeve t\u00eb pad\u00ebshiruara.<\/li>\n\n\n\n<li>Kontaktimi i sinjalizuesit p\u00ebr informacione t\u00eb m\u00ebtejshme.<\/li>\n\n\n\n<li>Analiza e sinjalizimeve t\u00eb Vigjilenc\u00ebs (mbik\u00ebqyrjes).<\/li>\n\n\n\n<li>Transmetimi i informacioneve tek Autoritetet Kompetente.<\/li>\n\n\n\n<li>Paraqitja ose mbrojtja e nj\u00eb t\u00eb drejte n\u00eb gjykim.<\/li>\n<\/ul>\n\n<p>Operacionet e trajtimit, t\u00eb cilat do t&#8217;i shpjegojm\u00eb imt\u00ebsisht m\u00eb posht\u00eb, kan\u00eb baz\u00ebn e tyre ligjore n\u00eb normat q\u00eb disiplinojn\u00eb t\u00eb drejt\u00ebn tuaj p\u00ebr mbrojtjen e t\u00eb dh\u00ebnave tuaja personale dhe t\u00eb drejt\u00ebn tuaj p\u00ebr privat\u00ebsi, q\u00eb do t\u00eb thot\u00eb:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>p\u00ebrmbushjen e detyrimeve kontraktuese t\u00eb marra p\u00ebrsip\u00ebr nga ABOCA n\u00eb interesin tuaj n\u00eb \u00e7astin blerjes ose p\u00ebrdorimit t\u00eb produkteve (Neni 6, germa b) e GDPR); <\/li>\n\n\n\n<li>p\u00ebrmbushjen e detyrimeve ose urdhrave p\u00ebr t\u00eb cilat Titullari i trajtimit \u00ebsht\u00eb i detyruar me ligj ose me urdh\u00ebr t\u00eb Autoritetit (Neni 6, germa c) e GDPR); <\/li>\n\n\n\n<li>motivet e interesit publik n\u00eb p\u00ebrputhje me Nenin 9, germa i) e GDPR dhe Neni 83 i Rregullores . BE 745 t\u00eb Parlamentit evropian dhe e K\u00ebshillit, t\u00eb 5 prillit 2017, n\u00eb lidhje me pajisjet mjek\u00ebsore;<\/li>\n\n\n\n<li>trajtimi \u00ebsht\u00eb i nevojsh\u00ebm p\u00ebr t\u00eb v\u00ebrtetuar, ushtruar ose mbrojtur nj\u00eb t\u00eb drejt\u00eb para gjyqit ose sa her\u00eb q\u00eb autoritetet gjyq\u00ebsore ushtrojn\u00eb funksionet e tyre gjyq\u00ebsore, Neni 9 germa f) i GDPR; <\/li>\n<\/ul>\n\n<p><strong>Marr\u00ebsit<\/strong><\/p>\n\n<p>T\u00eb dh\u00ebnat tuaja mund t&#8217;u komunikohen p\u00ebrgjegj\u00ebsve p\u00ebr trajtimin e tyre brenda fush\u00ebveprimit t\u00eb sh\u00ebrbimeve t\u00eb ofruara n\u00eb favor t\u00eb Aboca, brenda limiteve t\u00eb Nenit 28 GDPR, personelit t\u00eb brendsh\u00ebm p\u00ebrgjegj\u00ebs p\u00ebr administrimin e sinjalizimeve, bile, n\u00eb rastet e parashikuara, autoriteteve rregulluese kompetente p\u00ebr p\u00ebrmbushjen e detyrimeve ligjore ndaj t\u00eb cilave titullari \u00ebsht\u00eb subjekt i kontrollit t\u00eb t\u00eb dh\u00ebnave.<\/p>\n\n<p><strong>Periudha e ruajtjes s\u00eb t\u00eb dh\u00ebnave<\/strong><\/p>\n\n<p>N\u00eb p\u00ebrputhje me ligjin, n\u00eb cil\u00ebsin\u00eb e tij si fabrikues, OSA (Operatori i sektorit ushqimor), personi p\u00ebrgjegj\u00ebs p\u00ebrkat\u00ebs p\u00ebr pajisjet mjek\u00ebsore, integrator\u00ebt ushqimor\u00eb dhe kozmetik\u00ebt, ruan t\u00eb gjitha dokumentet n\u00eb lidhje me produktin, dhe t\u00eb dh\u00ebnat personale t\u00eb mbledhura n\u00eb lidhje me Vigjilenc\u00ebn, p\u00ebr nj\u00eb periudh\u00eb t\u00eb barabart\u00eb me koh\u00ebzgjatjen e vlefshm\u00ebris\u00eb s\u00eb autorizimit t\u00eb futjes n\u00eb treg, p\u00ebrtej 10 vjet\u00ebve t\u00eb tjera pas skadimit; megjithat\u00eb, periudha e ruajtjes s\u00eb t\u00eb dh\u00ebnave mund t\u00eb zgjatet n\u00ebse \u00ebsht\u00eb e nevojshme, sipas \u00e7do ras ti, p\u00ebr t\u00eb k\u00ebrkuar t\u00eb drejt\u00ebn ose p\u00ebr t\u00eb mbrojtur nj\u00eb t\u00eb drejt\u00eb n\u00eb gjykim.<\/p>\n\n<p><strong>Masat e siguris\u00eb<\/strong><\/p>\n\n<p>Adoptojm\u00eb masat e duhura p\u00ebr t\u00eb mbrojtur t\u00eb dh\u00ebnat personale q\u00eb trajtohen nga humbjet aksidentale dhe qasja, p\u00ebrdorimi, ndryshimi ose shp\u00ebrndarja e paautorizuar, n\u00ebp\u00ebrmjet aplikimit t\u00eb instrumenteve t\u00eb kriptimit dhe marr\u00ebdh\u00ebnieve me furnitor\u00ebt e caktuar shprehimisht si p\u00ebrgjegj\u00ebs t\u00eb trajtimit t\u00eb t\u00eb dh\u00ebnave n\u00eb p\u00ebrputhje me Nenin 28 GDPR<\/p>\n\n<p>Ne gjithashtu adoptojm\u00eb masa t\u00eb m\u00ebtejshme p\u00ebr sigurin\u00eb e informacioneve, nd\u00ebrmjet t\u00eb cilave kontrollet e akseseve, nj\u00eb siguri rigoroze fizike dhe praktika t\u00eb fuqishme t\u00eb grumbullimit, arkivimit dhe p\u00ebrpunimit t\u00eb informacioneve.<\/p>\n\n<p><strong>Transferime nd\u00ebrkomb\u00ebtare<\/strong><\/p>\n\n<p>N\u00eb rast se t\u00eb dh\u00ebnat duhet t\u00eb transferohen te subjekte t\u00eb themeluara n\u00eb vende jasht\u00eb BE-s\u00eb, do t\u00eb adoptohen her\u00eb pas here, instrumentet p\u00ebrkat\u00ebse p\u00ebr transferimin legjitim t\u00eb t\u00eb dh\u00ebnave, si\u00e7 jan\u00eb Vendimet e p\u00ebrshtatshm\u00ebris\u00eb s\u00eb BE-s\u00eb ose klauzolat kontraktuale standarde t\u00eb l\u00ebshuara nga Komisioni Evropian (nenet GDPR: 45, 46) ose p\u00ebrjashtime specifike t\u00eb aplikueshme (nenet GDPR 49).<\/p>\n\n<p><strong>T\u00eb drejtat e t\u00eb interesuarve<\/strong><\/p>\n\n<p>N\u00eb lidhje me trajtimet e p\u00ebrshkruara m\u00eb sip\u00ebr, n\u00eb \u00e7do moment, si subjekt i interesuar i t\u00eb dh\u00ebnave, mund t\u00eb ushtroni t\u00eb drejtat e parashikuara nga GDPR. N\u00eb p\u00ebrgjith\u00ebsi, personi i interesuar mund t\u00eb ushtroj\u00eb t\u00eb drejt\u00ebn p\u00ebr: <\/p>\n\n<ul class=\"wp-block-list\">\n<li>t\u00eb pasur qasje n\u00eb t\u00eb dh\u00ebnat e tij personale; t\u00eb marr\u00eb d\u00ebshmin\u00eb p\u00ebr q\u00ebllimet e ndjekura nga Titullari, p\u00ebr kategorit\u00eb e t\u00eb dh\u00ebnave t\u00eb trajtuara, t\u00eb marr\u00ebsve t\u00eb cil\u00ebve ato mund t&#8217;u komunikohen, p\u00ebr periudh\u00ebn e ruajtjes s\u00eb tyre, ekzistenc\u00ebn e proceseve t\u00eb automatizuara t\u00eb vendimmarrjes, duke p\u00ebrfshir\u00eb profilizimin, dhe, n\u00eb raste t\u00eb tilla, informacionin mbi logjik\u00ebn e p\u00ebrdorur dhe pasojat e mundshme p\u00ebr personat e interesuar;<\/li>\n\n\n\n<li>t\u00eb marr\u00eb pa vones\u00eb korrigjimin e t\u00eb dh\u00ebnave personale t\u00eb pasakta q\u00eb kan\u00eb t\u00eb b\u00ebjn\u00eb me t\u00eb;<\/li>\n\n\n\n<li>t\u00eb b\u00ebj\u00eb, n\u00eb rastet e parashikuara sipas ligjit, fshirjen e t\u00eb dh\u00ebnave q\u00eb i interesojn\u00eb;<\/li>\n\n\n\n<li>t\u00eb b\u00ebj\u00eb kufizimin e trajtimit n\u00eb rastet e parashikuara sipas ligjit;<\/li>\n\n\n\n<li>t\u00eb b\u00ebj\u00eb kund\u00ebrshtim p\u00ebr trajtimin, aty ku parashikohet, n\u00eb baz\u00eb t\u00eb normave t\u00eb aplikueshme sipas rastit specifik;<\/li>\n\n\n\n<li>n\u00eb rastet e parashikuara me ligj, t\u00eb b\u00ebj\u00eb transportueshm\u00ebrin\u00eb e t\u00eb dh\u00ebnave t\u00eb marra nga Titullari i trajtimit, si dhe t\u2019i marr\u00eb ato n\u00eb nj\u00eb format t\u00eb strukturuar, q\u00eb p\u00ebrdoret normalisht dhe t\u00eb lexuesh\u00ebm nga dispozitiv\u00ebt automatik\u00eb ose t\u00eb k\u00ebrkoj\u00eb transmetimin e k\u00ebtyre t\u00eb dh\u00ebnave te nj\u00eb Titullar tjet\u00ebr, aty ku \u00ebsht\u00eb e mundur;<\/li>\n\n\n\n<li>n\u00ebse konsiderohet e p\u00ebrshtatshme, t\u00eb paraqes\u00eb nj\u00eb ankes\u00eb pran\u00eb Autoritetit Garant p\u00ebr mbrojtjen e t\u00eb dh\u00ebnave personale n\u00eb shtetin e tij.<\/li>\n<\/ul>\n\n<div style=\"height:84px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Privacy Notice \u2013 Pharmacovigilance System Neni 13 Regj. BE 679 m\u00eb 27 Prill 2016 N\u00eb p\u00ebrputhje me Nenin 13 t\u00eb Rregullores Evropiane 2016\/679 (GDPR), p\u00ebr mbrojtjen e personave fizik\u00eb n\u00eb lidhje me trajtimin e t\u00eb dh\u00ebnave personale dhe qarkullimin e lir\u00eb t\u00eb k\u00ebtyre t\u00eb dh\u00ebnave, ABOCA S.p.A. Shoq\u00ebri Bujq\u00ebsore (n\u00eb vijim \u201cABOCA\u201d), me seli n\u00eb<\/p>\n","protected":false},"author":23,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"templates\/dynamic-institutional-level3.php","meta":{"_acf_changed":false,"inline_featured_image":false,"kk_blocks_editor_width":"","_kiokenblocks_attr":"","_kiokenblocks_dimensions":"","footnotes":""},"class_list":["post-124670","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Informativa e privat\u00ebsis\u00eb - Sistemi i Farmakovigjilenc\u00ebs - Aboca<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.aboca.com\/sq\/informativa-e-privatesise-sistemi-i-farmakovigjilences\/\" \/>\n<meta property=\"og:locale\" content=\"sq_AL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Informativa e privat\u00ebsis\u00eb - Sistemi i Farmakovigjilenc\u00ebs - Aboca\" \/>\n<meta property=\"og:description\" content=\"Privacy Notice \u2013 Pharmacovigilance System Neni 13 Regj. BE 679 m\u00eb 27 Prill 2016 N\u00eb p\u00ebrputhje me Nenin 13 t\u00eb Rregullores Evropiane 2016\/679 (GDPR), p\u00ebr mbrojtjen e personave fizik\u00eb n\u00eb lidhje me trajtimin e t\u00eb dh\u00ebnave personale dhe qarkullimin e lir\u00eb t\u00eb k\u00ebtyre t\u00eb dh\u00ebnave, ABOCA S.p.A. Shoq\u00ebri Bujq\u00ebsore (n\u00eb vijim \u201cABOCA\u201d), me seli n\u00eb\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.aboca.com\/sq\/informativa-e-privatesise-sistemi-i-farmakovigjilences\/\" \/>\n<meta property=\"og:site_name\" content=\"Aboca\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-04T08:44:27+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"11 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.aboca.com\/sq\/informativa-e-privatesise-sistemi-i-farmakovigjilences\/\",\"url\":\"https:\/\/www.aboca.com\/sq\/informativa-e-privatesise-sistemi-i-farmakovigjilences\/\",\"name\":\"Informativa e privat\u00ebsis\u00eb - Sistemi i Farmakovigjilenc\u00ebs - Aboca\",\"isPartOf\":{\"@id\":\"https:\/\/www.aboca.com\/sq\/#website\"},\"datePublished\":\"2025-07-22T10:22:09+00:00\",\"dateModified\":\"2026-03-04T08:44:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.aboca.com\/sq\/informativa-e-privatesise-sistemi-i-farmakovigjilences\/#breadcrumb\"},\"inLanguage\":\"sq-AL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.aboca.com\/sq\/informativa-e-privatesise-sistemi-i-farmakovigjilences\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.aboca.com\/sq\/informativa-e-privatesise-sistemi-i-farmakovigjilences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.aboca.com\/sq\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Informativa e privat\u00ebsis\u00eb &#8211; Sistemi i Farmakovigjilenc\u00ebs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.aboca.com\/sq\/#website\",\"url\":\"https:\/\/www.aboca.com\/sq\/\",\"name\":\"Aboca\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.aboca.com\/sq\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sq-AL\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Informativa e privat\u00ebsis\u00eb - Sistemi i Farmakovigjilenc\u00ebs - Aboca","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.aboca.com\/sq\/informativa-e-privatesise-sistemi-i-farmakovigjilences\/","og_locale":"sq_AL","og_type":"article","og_title":"Informativa e privat\u00ebsis\u00eb - Sistemi i Farmakovigjilenc\u00ebs - Aboca","og_description":"Privacy Notice \u2013 Pharmacovigilance System Neni 13 Regj. BE 679 m\u00eb 27 Prill 2016 N\u00eb p\u00ebrputhje me Nenin 13 t\u00eb Rregullores Evropiane 2016\/679 (GDPR), p\u00ebr mbrojtjen e personave fizik\u00eb n\u00eb lidhje me trajtimin e t\u00eb dh\u00ebnave personale dhe qarkullimin e lir\u00eb t\u00eb k\u00ebtyre t\u00eb dh\u00ebnave, ABOCA S.p.A. Shoq\u00ebri Bujq\u00ebsore (n\u00eb vijim \u201cABOCA\u201d), me seli n\u00eb","og_url":"https:\/\/www.aboca.com\/sq\/informativa-e-privatesise-sistemi-i-farmakovigjilences\/","og_site_name":"Aboca","article_modified_time":"2026-03-04T08:44:27+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"11 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.aboca.com\/sq\/informativa-e-privatesise-sistemi-i-farmakovigjilences\/","url":"https:\/\/www.aboca.com\/sq\/informativa-e-privatesise-sistemi-i-farmakovigjilences\/","name":"Informativa e privat\u00ebsis\u00eb - Sistemi i Farmakovigjilenc\u00ebs - Aboca","isPartOf":{"@id":"https:\/\/www.aboca.com\/sq\/#website"},"datePublished":"2025-07-22T10:22:09+00:00","dateModified":"2026-03-04T08:44:27+00:00","breadcrumb":{"@id":"https:\/\/www.aboca.com\/sq\/informativa-e-privatesise-sistemi-i-farmakovigjilences\/#breadcrumb"},"inLanguage":"sq-AL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.aboca.com\/sq\/informativa-e-privatesise-sistemi-i-farmakovigjilences\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.aboca.com\/sq\/informativa-e-privatesise-sistemi-i-farmakovigjilences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.aboca.com\/sq\/"},{"@type":"ListItem","position":2,"name":"Informativa e privat\u00ebsis\u00eb &#8211; Sistemi i Farmakovigjilenc\u00ebs"}]},{"@type":"WebSite","@id":"https:\/\/www.aboca.com\/sq\/#website","url":"https:\/\/www.aboca.com\/sq\/","name":"Aboca","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.aboca.com\/sq\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sq-AL"}]}},"_links":{"self":[{"href":"https:\/\/www.aboca.com\/sq\/wp-json\/wp\/v2\/pages\/124670","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aboca.com\/sq\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.aboca.com\/sq\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.aboca.com\/sq\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aboca.com\/sq\/wp-json\/wp\/v2\/comments?post=124670"}],"version-history":[{"count":1,"href":"https:\/\/www.aboca.com\/sq\/wp-json\/wp\/v2\/pages\/124670\/revisions"}],"predecessor-version":[{"id":124671,"href":"https:\/\/www.aboca.com\/sq\/wp-json\/wp\/v2\/pages\/124670\/revisions\/124671"}],"wp:attachment":[{"href":"https:\/\/www.aboca.com\/sq\/wp-json\/wp\/v2\/media?parent=124670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}